About
LuxMed Systems, Inc. is the leader in second-generation, sensor-based pulsed field ablation (PFA) and radiofrequency therapeutic cardiac ablation and opto-anatomical mapping, enabling unprecedented real-time assessment of lesion quality, durability and gap detection. The resultant clinical value proposition is improved lesion durability and reduced recurrence rates which will substantially benefit patients, hospital systems and payors.
Technologies
Outlook
Cedexis Radar
Weebly
Adobe Media Optimizer
Google Font API
reCAPTCHA
Google Analytics
Mobile Friendly
Vimeo
AI
Keywords
optical tissue interrogation during ablation
metabolic activity
lesion and gap detection
tissue viability
real-time lesion monitoring
healthcare technology
catheter movement tracking
catheter contact stability
pfa ablation
optical tissue interrogation
optical assessment of tissue contact
electroporation
metabolic tissue signatures
ip portfolio
b2b
clinical data
lesion formation
optical assessment
catheter movement
life sciences
lesion detection
advanced electrophysiology tools
ablation catheter
metabolic activity monitoring
animal model testing
medical devices
rf ablation
optically enabled rf catheters
cardiovascular devices
medical equipment and supplies manufacturing
Company Information
-
Employees 15
-
Founded 2019
Location
Cambridge, Massachusetts, United States
